Previous Close | 3.8000 |
Open | 3.8000 |
Bid | 2.1500 |
Ask | 5.3000 |
Strike | 5.00 |
Expire Date | 2025-01-17 |
Day's Range | 3.8000 - 3.8000 |
Contract Range | N/A |
Volume | |
Open Interest | 1.13k |
Key Insights Significant control over Mind Medicine (MindMed) by retail investors implies that the general public has...
NEW YORK, May 28, 2024--Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that members of the Company’s management team will participate in the following conferences:
NEW YORK, May 09, 2024--Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that members of the Company’s management team will participate in the following investor conferences: